Lupin’s US generics chief and global head of generics research and development and biosimilars, Alok Sonig, has been named by the US Association for Accessible Medicines as chair of the AAM’s board for 2020.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?